CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Valneva SE Company Snapshot
Valneva SE operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Valneva SE with three other pharmaceutical manufacturers in Europe: New Nordic Healthbrands AB of SWEDEN (2019 sales of 452.61 million Swedish Kronor [US$51.58 million] ), Eczacibasi Ilac Sanayi ve T.A.S. of TURKEY (877.08 million Turkish Liras [US$115.82 million] of which 85% was Health), and Science In Sport Plc which is based in UNITED KINGDOM (£50.57 million [US$65.51 million] of which 51% was PhD).

Sales Analysis. During the year ended December of 2019, sales at Valneva SE were 126.20 million Euro (US$149.52 million). This is an increase of 11.6% versus 2018, when the company's sales were 113.04 million Euro. This was the fifth consecutive year of sales increases at Valneva SE (and since 2014, sales have increased a total of 242%). Sales of Commercialized Vaccines saw an increase that was more than double the company's growth rate: sales were up 25.1% in 2019, from 103.65 million Euro to 129.67 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Valneva SE
  Stock Performance Chart for Valneva SE
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 6.58
(Figures in Euros )
1 Week 29.0%   13 Weeks 17.9%  
4 Weeks 44.8%   52 Weeks 120.1%  
 
Valneva SE Key Data:
  Ticker: VLA Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 126,196,000
(Year Ending Jan 2020).
Employees: 508
  Currency: Euros Market Cap: 597,592,244
  Fiscal Yr Ends: December Shares Outstanding: 90,819,490
  Share Type: Actions Ordinaires Closely Held Shares: 14,430,028
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.